Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Plasmodesmata02:32

Plasmodesmata

36.0K
The organs in a multicellular organism’s body are made up of tissues formed by cells. To work together cohesively, cells must communicate. One way that cells communicate is through direct contact with other cells. The points of contact that connect adjacent cells are called intercellular junctions.
36.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same author

Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.

HemaSphere·2026
Same author

Evolving Paradigms in the Treatment of Philadelphia Chromosome-Positive ALL.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Blood·2026
Same author

Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.

Transplantation and cellular therapy·2026

Related Experiment Video

Updated: Mar 15, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K

[Plasmablastic lymphoma].

Rubén Fernández-Álvarez1, Juan-Manuel Sancho2, Josep-María Ribera2

  • 1Servicio de Hematología, Hospital Universitario de Cabueñes, Gijón, Asturias, España.

Medicina Clinica
|September 1, 2016
PubMed
Summary

Plasmablastic lymphoma (PBL) is an aggressive cancer often seen in HIV-positive individuals. This review covers PBL

Keywords:
BortezomibChemotherapyHuman immunodeficiency virus infectionInfección por el virus de la inmunodeficiencia humanaLinfoma plasmablásticoMYCOncogén MYCPlasmablastic lymphomaQuimioterapia

More Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

953
Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

12.3K

Related Experiment Videos

Last Updated: Mar 15, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

953
Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

12.3K

Area of Science:

  • Hematology and Oncology
  • Infectious Diseases

Background:

  • Plasmablastic lymphoma (PBL) is a rare, aggressive non-Hodgkin lymphoma.
  • PBL predominantly affects oral sites in human immunodeficiency virus (HIV)-positive individuals.
  • PBL also occurs in HIV-negative patients and can involve non-oral sites.

Purpose of the Study:

  • To review the clinical and epidemiologic spectrum of Plasmablastic lymphoma.
  • To discuss the distinct pathological features of PBL.
  • To summarize current treatment approaches for PBL.

Main Methods:

  • Literature review of clinical studies, pathological findings, and treatment outcomes for PBL.
  • Analysis of epidemiological data concerning PBL prevalence and risk factors.
  • Synthesis of information on immunophenotypic and genetic characteristics of PBL.

Main Results:

  • PBL is characterized by a terminally differentiated B-lymphocyte immunophenotype with CD20 loss and plasma cell antigen expression.
  • Epstein-Barr virus infection and MYC rearrangements are frequently detected in PBL.
  • Treatment of PBL remains challenging, with a median survival of less than one year.

Conclusions:

  • PBL presents unique clinical, epidemiological, and pathological features.
  • Effective treatment strategies for PBL are limited, necessitating further research.
  • Understanding PBL's characteristics is crucial for improving patient outcomes.